Shukra Pharmaceuticals Ltd — Insider Trading, 20-03-2026: Insider Trading / SAST

Shukra Pharmaceuticals has closed its trading window for designated persons and their relatives from April 1, 2026. This restriction will remain until 48 hours after the company declares its financial results for the quarter and year ended March 31, 2026. This measure ensures fair play by preventing insider trading ahead of the crucial financial disclosure. The company will announce the board meeting date for these results soon. This is a routine compliance update, indicating that investors should soon expect an update on the company's full-year financial performance.